Company intelligence / Profile preview

Exosystems

Seongnam-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Exosystems has developed and commercialized a wearable neurorehabilitation and musculoskeletal digital care system that combines sensors, AI-driven digital biomarkers, and functional electrical stimulation; its device has obtained approval from the Korean Ministry of Food and Drug Safety and CE-MDD in Europe and is reimbursed under Korean public health insurance, with clinical validation conducted in collaboration with major Korean hospitals.[2]

Therapeutic areas: NeurologyRheumatology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Seoul National University Bundang Hospital (clinical research collaboration)[2]Other prominent Korean medical institutions for clinical research (unnamed)[2]Korean government-funded R&D project (USD 5M scale)[2]

Beyond the preview

Go deeper on Exosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exosystems.

Explore the full profile